Labcorp Holdings Inc logo

Labcorp Holdings Inc

7
2
NYSE:LH (USA)   Ordinary Shares
$ 199.65 +3.28 (+1.67%) 10:08 PM EST
40.33
P/B:
2.11
Market Cap:
$ 16.83B
Enterprise V:
$ 22.70B
Volume:
724.59K
Avg Vol (2M):
735.51K
Also Trade In:
Volume:
724.59K
Avg Vol (2M):
735.51K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for LH ( Labcorp Holdings Inc ) from 1991 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Labcorp stock (LH) PE ratio as of May 26 2024 is 40.33. More Details

Labcorp Holdings Inc (LH) PE Ratio (TTM) Chart

To

Labcorp Holdings Inc (LH) PE Ratio (TTM) Historical Data

Total 1237
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Labcorp PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 40.3 2024-03-22 45.9
2024-05-24 40.3 2024-03-21 45.4
2024-05-23 39.8 2024-03-20 45.0
2024-05-22 40.6 2024-03-19 45.4
2024-05-21 41.5 2024-03-18 45.1
2024-05-20 41.8 2024-03-15 45.0
2024-05-17 42.5 2024-03-14 45.0
2024-05-16 43.1 2024-03-13 46.4
2024-05-15 43.1 2024-03-12 46.6
2024-05-14 42.7 2024-03-11 47.0
2024-05-13 42.5 2024-03-08 46.8
2024-05-10 42.0 2024-03-07 47.0
2024-05-09 41.6 2024-03-06 46.8
2024-05-08 40.7 2024-03-05 46.5
2024-05-07 40.7 2024-03-04 47.1
2024-05-06 40.6 2024-03-01 46.9
2024-05-03 40.7 2024-02-29 46.4
2024-05-02 40.5 2024-02-28 46.2
2024-05-01 40.7 2024-02-27 46.4
2024-04-30 40.7 2024-02-26 46.3
2024-04-29 41.3 2024-02-23 47.1
2024-04-26 40.1 2024-02-22 46.8
2024-04-25 40.1 2024-02-21 46.9
2024-04-24 42.0 2024-02-20 46.4
2024-04-23 42.0 2024-02-16 46.6
2024-04-22 41.0 2024-02-15 47.8
2024-04-19 40.7 2024-02-14 49.1
2024-04-18 40.3 2024-02-13 48.0
2024-04-17 40.4 2024-02-12 48.9
2024-04-16 40.8 2024-02-09 47.9
2024-04-15 41.1 2024-02-08 47.9
2024-04-12 41.6 2024-02-07 48.1
2024-04-11 41.7 2024-02-06 47.8
2024-04-10 41.9 2024-02-05 47.2
2024-04-09 42.4 2024-02-02 47.6
2024-04-08 42.5 2024-02-01 48.2
2024-04-05 42.7 2024-01-31 47.8
2024-04-04 42.7 2024-01-30 48.7
2024-04-03 42.9 2024-01-29 48.9
2024-04-02 42.8 2024-01-26 48.4
2024-04-01 43.7 2024-01-25 48.7
2024-03-28 44.1 2024-01-24 48.0
2024-03-27 46.6 2024-01-23 48.8
2024-03-26 45.9 2024-01-22 48.5
2024-03-25 46.0 2024-01-19 48.6

Labcorp Holdings Inc (LH) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Labcorp Holdings Inc logo
Labcorp Holdings Inc
NAICS : 621511 SIC : 8071
ISIN : US50540R4092

Share Class Description:

LH: Ordinary Shares
Description
Labcorp Holdings Inc is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.